Ginkgo Bioworks

The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) and Ginkgo Bioworks Holdings Inc. (NYSE:DNA) rallying last week. What Happened: On...

Global merger and acquisition activity topped $1 trillion in the second quarter of 2021, with the U.S alone topping $500 billion. This was the third quarter in a row that this happened globally and in the U.S. The second quarter started strong with four of the five largest deals announced in the...

A well seasoned SPAC management team announced a SPAC deal Tuesday to bring a cell programming company public. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with Soaring Eagle Acquisition Corp (NASDAQ: SRNG) that values the company at a pre money equity value of $15 billion. Soaring...

Synlogic, Inc. (NASDAQ: SYBX) announced a platform collaboration to speed up the development of Synlogic’s pipeline of Synthetic Biotic medicines using Ginkgo’s cell programming platform. The agreement provides an $80.0 million equity investment at a premium in Synlogic by Ginkgo and...